Efficacy of low dose intravenous immunoglobulins for post-splenectomy treatment of autoimmune haemolytic anaemia in a patient with hereditary spherocytosis.
Summary Idiopathic autoimmune haemolytic anaemia developed in a patient with hereditary spherocytosis. The behaviour of some osmotic fragility tests throughout the illness and the efficacy of intravenous immunoglobulins in controlling autoimmune haemolysis which recurred post splenectomy are discussed
Ames
P R
PR
Department of Haematology, Guy's & St Thomas' Hospital Trust, London, UK. pames@rayne.umds.ac.uk
Nardiello
S
S
Tommasino
C
C
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000209:etiology; D005192:Family Health; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000592:standards* / Q000627:therapeutic use; D008297:Male; D013103:Spherocytosis, Hereditary / Q000150:complications / Q000188:drug therapy; D013156:Splenectomy; D013997:Time Factors
D016756:Immunoglobulins, Intravenous